Retrospective analysis of lactic acidosis-related parameters upon and after metformin discontinuation in patients with diabetes and chronic kidney disease

Autor: Ali Tamer, Mehmet Yildirim, Ahmed Bilal Genc, Ülkü Yılmaz, Ahmet Nalbant, Seyyid Bilal Acikgoz, Yalcin Solak, Savas Sipahi
Přispěvatelé: Sipahi, S, Solak, Y, Acikgoz, SB, Genc, AB, Yildirim, M, Yilmaz, U, Nalbant, A, Tamer, A, Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü, Sipahi, Savaş, Yıldırım, Mehmet, Nalbant, Ahmet, Tamer, Ali
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Adult
Male
medicine.medical_specialty
endocrine system diseases
Urology
Renal function
030209 endocrinology & metabolism
Comorbidity
Type 2 diabetes
Risk Assessment
Severity of Illness Index
Gastroenterology
Statistics
Nonparametric

Cohort Studies
03 medical and health sciences
0302 clinical medicine
Diabetes mellitus
Internal medicine
Humans
Hypoglycemic Agents
Medicine
Renal Insufficiency
030212 general & internal medicine
Renal Insufficiency
Chronic

Aged
Retrospective Studies
business.industry
nutritional and metabolic diseases
Metabolic acidosis
Middle Aged
Urology & Nephrology
medicine.disease
Metformin
Discontinuation
Endocrinology
Diabetes Mellitus
Type 2

Withholding Treatment
Nephrology
Creatinine
Lactic acidosis
Linear Models
Acidosis
Lactic

Female
Hyperlactatemia
business
Follow-Up Studies
Glomerular Filtration Rate
medicine.drug
Popis: To investigate association between renal functions, lactic acid levels and acid–base balance in type 2 diabetes patients with chronic kidney disease under metformin treatment and after metformin discontinuation in a real-life setting. A total of 65 patients with diabetes (mean age 68.5 ± 8.9 years, 56.9 % females) in whom metformin treatment was discontinued due to reduced glomerular filtration rate (GFR) were included in this retrospective study. Data on patient demographics, metformin treatment and laboratory findings on the last day of metformin treatment and 2–3 weeks after metformin discontinuation including blood lactate and creatinine, estimated glomerular filtration rate (eGFR) and acid–base balance measurements in blood [pH, bicarbonate, base excess] were collected from medical records. The correlation of lactate levels with eGFR, blood pH and creatinine levels and changes in laboratory findings after metformin discontinuation were evaluated. Before metformin discontinuation, hyperlactatemia was observed in 78.5 % of patients and metabolic acidosis in 36.9 % of patients, but none had lactic acidosis. Patients with normolactatemia and hyperlactatemia were similar in terms of metformin dosage and laboratory parameters. Lactate levels were not significantly correlated with serum creatinine (r = −0.14; p = 0.263) and eGFR (r = 0.11, p = 0.374). After metformin discontinuation, a significant decrease was observed in median lactate levels (from 2.20 to 1.85 mmol/L; p = 0.002). In conclusion, our findings support the low risk of MALA among patients with mild-to-moderate renal impairment and the likelihood of metformin to be an innocent bystander without a pathogenic role in the lactic acidosis in most cases.
Databáze: OpenAIRE